Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.
340B Health, Researchers Spar over Biosimilar Study
Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.